ProFunds Biotechnology UltraSector Svc (BIPSX)
168.21
3.99(2.43%) Oct 1
| Prev Close: | 168.21 |
|---|
| YTD Return*: | 68.48% |
|---|
| Net Assets*: | 354.89M |
|---|
| Yield*: | N/A |
|---|
* As of 31-Aug-13
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Top Ranked Biotech Mutual Funds Surging HigherZacks(Thu, Sep 26)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Tue, Sep 17)
- 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Thu, Jul 25)
- Zacks #1 Ranked Healthcare Mutual FundsZacks(Wed, Jul 3)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, May 29)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Thu, May 16)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Fri, May 3)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Tue, Apr 23)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Tue, Apr 9)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Thu, Jan 24)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Tue, Jan 15)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Tue, Dec 11)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Oct 17)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Aug 1)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Jun 13)
Fund Basics
| Morningstar Overall Rating: | |
| Total Assets: | 354.89M |
| Category: | Trading-Leveraged Equity |
|---|
| Annual Report Expense Ratio (net): | 2.73% |
|---|
Performance & Risk
| YTD Return: | 68.48% |
| 5y Avg Return: | 19.42% |
| Rank in Category (ytd): | 1 |
| % Rank in Category (ytd): | 0.95% |
| Beta (3y): | 1.36 |
| Morningstar Risk Rating: | 5 |
Fund Summary
The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the Dow Jones U.S. BiotechnologySM Index.
The fund invests in securities and derivatives that the adviser believes, in combination, should have similar daily return characteristics as one and one-half times (1.5x) the daily return of the index. The index measures the performance of the biotechnology sector of the U.S. equity market. It is non-diversified.
View More